Emerson (NYSE:EMR) was downgraded by Oppenheimer (NYSE:OPY) to outperform from perform with a price target of $53 due to a lack of catalysts to drive the price higher in the near term
Shares are lower by nearly nine tenths of a percent.
Cliffs Natural (NYSE:CLF) was downgraded by Goldman Sachs (NYSE:GS) to sell with a price target of $25 due to higher costs and a potential production target miss.
Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes
only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners.
In no way should any content contained herein be interpreted to represent trading or investment advice.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.
Launch related slideshow:
